Ingredient
Ethylhexyl P-Methoxycinnamate
Ethylhexyl P-Methoxycinnamate is flagged for pregnancy, breastfeeding, trying to conceive, postpartum, PCOS and general use. The concern behind the strongest flag is endocrine disruptor and absorbed into the body.
- Octinoxate
- Octyl Methoxycinnamate
- OMC
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Ethylhexyl P-Methoxycinnamate and pregnancy
Not Recommended
- Endocrine disruptor
- Absorbed into the body
- Hormone disruptor
Ethylhexyl p-methoxycinnamate, commonly known as octinoxate, is a chemical UV filter widely used in sunscreens to absorb UVB radiation. It's one of the most common sunscreen ingredients globally. This ingredient raises concerns during pregnancy due to its endocrine-disrupting potential. Studies have demonstrated that octinoxate can penetrate the skin and be detected in blood plasma, with systemic absorption rates higher than previously thought. Research has shown weak estrogenic activity in laboratory studies, and animal studies suggest potential effects on reproductive development and thyroid function. While human pregnancy studies are limited, the combination of documented systemic absorption and hormone-like activity leads many obstetricians and dermatologists to recommend caution. While the FDA has not explicitly prohibited octinoxate during pregnancy, the agency has called for additional safety data regarding systemic exposure. ACOG recommends pregnant women prioritize mineral sunscreens (zinc oxide, titanium dioxide) over chemical filters when possible due to mounting evidence of chemical UV filter absorption and endocrine effects. Most dermatologists advise switching to mineral-based sunscreens during pregnancy as a precautionary measure.
Ethylhexyl P-Methoxycinnamate and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
- Endocrine disruptor
Octinoxate is a chemical UV filter that has been studied for its absorption and distribution in the body, including detection in breast milk samples. Research has detected octinoxate in breast milk, indicating that this lipophilic (fat-soluble) compound can transfer to breastfed infants. A Swiss study found UV filter chemicals, including octinoxate, in breast milk samples from women who regularly used sunscreen. The concern is not just the presence but the potential for these chemicals to affect infant hormone systems during critical developmental periods. Given that infants have immature detoxification systems and developing endocrine systems, exposure to compounds with estrogenic activity poses theoretical risks. The AAD notes that while sunscreen use is important during breastfeeding, mineral sunscreens may be preferable to chemical filters due to concerns about systemic absorption and milk transfer. Most dermatologists recommend breastfeeding mothers choose zinc oxide or titanium dioxide-based sunscreens instead of chemical filters like octinoxate.
Ethylhexyl P-Methoxycinnamate and postpartum
Caution Advised
- Endocrine disruptor
For postpartum women not breastfeeding, octinoxate carries moderate concerns related to its endocrine-disrupting potential. While there's no risk of infant exposure through milk, the systemic absorption and hormone-like activity remain relevant. Some women may prefer to continue avoiding endocrine-disrupting compounds during the postpartum period, particularly if planning future pregnancies. However, the risk is lower than during pregnancy or breastfeeding. Mineral sunscreens remain a safer alternative for those concerned about hormone disruption.
Ethylhexyl P-Methoxycinnamate and trying to conceive
Not Recommended
- Hormone disruptor
- Fertility effects
Women trying to conceive are advised to minimize exposure to endocrine-disrupting compounds, as hormonal balance is crucial for fertility and early pregnancy development (often before pregnancy is confirmed). Octinoxate's estrogenic activity and systemic absorption make it a concern for women TTC. Some reproductive endocrinologists recommend switching to mineral sunscreens when trying to conceive, as a precautionary approach to optimize hormonal health and reduce potential interference with conception or early fetal development.
Ethylhexyl P-Methoxycinnamate and PCOS
Caution Advised
- Interferes with hormones
- Endocrine disruptor
Octinoxate is a chemical UV filter with documented estrogenic activity in laboratory studies. Given that PCOS involves hormonal imbalances, particularly elevated androgens, exposure to endocrine-disrupting compounds warrants consideration. While direct studies on octinoxate and PCOS are lacking, the ingredient's ability to mimic estrogen and potentially interfere with hormone signaling could theoretically affect the already complex hormonal balance in PCOS. Some endocrinologists recommend that women with hormonal conditions minimize exposure to known endocrine disruptors when feasible. For women with PCOS, mineral sunscreens (zinc oxide or titanium dioxide) may be a better choice, as they provide UV protection without hormonal activity. However, the risk from topical octinoxate use is likely small compared to other environmental hormone disruptors.
Ethylhexyl P-Methoxycinnamate and general use
Caution Advised
- Endocrine disruptor
- Common allergen
Ethylhexyl p-methoxycinnamate (octinoxate) is one of the most widely used chemical UV filters in sunscreens worldwide. It effectively absorbs UVB radiation, helping to prevent sunburn and UV damage. The primary concern with octinoxate is its potential endocrine-disrupting activity. Multiple studies have demonstrated that this ingredient can penetrate the skin barrier and be absorbed systemically, appearing in blood and urine after sunscreen application. Laboratory studies have shown weak estrogenic effects, and some animal studies suggest effects on reproductive organs and thyroid function. A 2020 FDA study found that octinoxate reaches plasma concentrations exceeding the FDA threshold for toxicology assessment after just one day of use. While these findings don't prove harm in humans, they have raised concerns about chronic exposure. The FDA continues to evaluate the safety of octinoxate and other chemical UV filters, having moved them from 'generally recognized as safe and effective' (GRASE) to requiring additional data. The European Commission's Scientific Committee on Consumer Safety has also reviewed endocrine disruption concerns. Despite these concerns, octinoxate remains approved for use, and many experts note that the benefits of sun protection may outweigh potential risks for most adults. However, mineral sunscreens offer an alternative without hormone-disrupting concerns.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Ethylhexyl P-Methoxycinnamate, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store